Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus
Clinical trial NCT01262365 · COMPLETED
Trial details
- NCT number
- NCT01262365
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2015-05-01
- Enrollment
- 793
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.